Literature DB >> 18599352

Flipping the paradigm on malaria transmission-blocking vaccines.

Rhoel R Dinglasan1, Marcelo Jacobs-Lorena.   

Abstract

The idea of malaria transmission-blocking vaccines (TBVs) surfaced more than two decades ago. Since then, the research paradigm focused on developing TBVs that target surface antigens of parasite sexual stages. Only recently has an effort emerged that flipped this paradigm, targeting antigens of the parasite's obligate invertebrate vector, the Anopheles mosquito. Here, we review the current state of knowledge of mosquito-based TBVs and discuss the utility of this approach for future vaccine development.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18599352      PMCID： PMC4153682          DOI： 10.1016/j.pt.2008.05.002

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


  53 in total

1.  A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.

Authors:  V Verez-Bencomo; V Fernández-Santana; Eugenio Hardy; Maria E Toledo; Maria C Rodríguez; Lazaro Heynngnezz; Arlene Rodriguez; Alberto Baly; Luis Herrera; Mabel Izquierdo; Annette Villar; Yury Valdés; Karelia Cosme; Mercedes L Deler; Manuel Montane; Ernesto Garcia; Alexis Ramos; Aristides Aguilar; Ernesto Medina; Gilda Toraño; Iván Sosa; Ibis Hernandez; Raydel Martínez; Alexis Muzachio; Ania Carmenates; Lourdes Costa; Félix Cardoso; Concepción Campa; Manuel Diaz; René Roy
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

2.  Characterization of a unique human single-chain antibody isolated by phage-display selection on membrane-bound mosquito midgut antigens.

Authors:  Brian D Foy; Gerry F Killeen; Ross H Frohn; Daniel Impoinvil; Andrew Williams; John C Beier
Journal:  J Immunol Methods       Date:  2002-03-01       Impact factor: 2.303

3.  Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies.

Authors:  S Kamhawi; Y Belkaid; G Modi; E Rowton; D Sacks
Journal:  Science       Date:  2000-11-17       Impact factor: 47.728

4.  Induction of Plasmodium falciparum transmission-blocking antibodies in nonhuman primates by a combination of DNA and protein immunizations.

Authors:  Cevayir Coban; Mario T Philipp; Jeanette E Purcell; David B Keister; Mobolaji Okulate; Dale S Martin; Nirbhay Kumar
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Monoclonal antibody MG96 completely blocks Plasmodium yoelii development in Anopheles stephensi.

Authors:  Rhoel R Dinglasan; Iesha Fields; Mohammed Shahabuddin; Abdu F Azad; John B Sacci
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 6.  Transmission-blocking vaccine of vivax malaria.

Authors:  Takafumi Tsuboi; Mayumi Tachibana; Osamu Kaneko; Motomi Torii
Journal:  Parasitol Int       Date:  2003-03       Impact factor: 2.230

7.  Blocking of transmission to mosquitoes by antibody to Plasmodium vivax malaria vaccine candidates Pvs25 and Pvs28 despite antigenic polymorphism in field isolates.

Authors:  Jetsumon Sattabongkot; Takafumi Tsuboi; Hajime Hisaeda; Mayumi Tachibana; Nantavadee Suwanabun; Thanaporn Rungruang; Ya-Ming Cao; Anthony W Stowers; Jeeraphat Sirichaisinthop; Russell E Coleman; Motomi Torii
Journal:  Am J Trop Med Hyg       Date:  2003-11       Impact factor: 2.345

8.  Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes.

Authors:  Takeshi Arakawa; Takafumi Tsuboi; Ayano Kishimoto; Jetsumon Sattabongkot; Nantavadee Suwanabun; Thanaporn Rungruang; Yasunobu Matsumoto; Naotoshi Tsuji; Hajime Hisaeda; Anthony Stowers; Isao Shimabukuro; Yoshiya Sato; Motomi Torii
Journal:  Vaccine       Date:  2003-07-04       Impact factor: 3.641

9.  Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein.

Authors:  J G Valenzuela; Y Belkaid; M K Garfield; S Mendez; S Kamhawi; E D Rowton; D L Sacks; J M Ribeiro
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

10.  A tubular network associated with the brush-border surface of the Aedes aegypti midgut: implications for pathogen transmission by mosquitoes.

Authors:  H Zieler; C F Garon; E R Fischer; M Shahabuddin
Journal:  J Exp Biol       Date:  2000-05       Impact factor: 3.312
View more
  39 in total

1.  Vaccines: The take-home lesson.

Authors:  Sarah DeWeerdt
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

2.  Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine.

Authors:  D K Mathias; J L Plieskatt; J S Armistead; J M Bethony; K B Abdul-Majid; A McMillan; E Angov; M J Aryee; B Zhan; P Gillespie; B Keegan; A R Jariwala; W Rezende; M E Bottazzi; D G Scorpio; P J Hotez; R R Dinglasan
Journal:  Infect Immun       Date:  2012-02-06       Impact factor: 3.441

Review 3.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

4.  Synergistic and antagonistic interactions between bednets and vaccines in the control of malaria.

Authors:  Yael Artzy-Randrup; Andrew P Dobson; Mercedes Pascual
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

5.  The fibrinogen-like domain of FREP1 protein is a broad-spectrum malaria transmission-blocking vaccine antigen.

Authors:  Guodong Niu; Caio Franc A; Genwei Zhang; Wanlapa Roobsoong; Wang Nguitragool; Xiaohong Wang; Jetsumon Prachumsri; Noah S Butler; Jun Li
Journal:  J Biol Chem       Date:  2017-05-22       Impact factor: 5.157

6.  Mosquito ingestion of antibodies against mosquito midgut microbiota improves conversion of ookinetes to oocysts for Plasmodium falciparum, but not P. yoelii.

Authors:  Bruce H Noden; Jefferson A Vaughan; Charles B Pumpuni; John C Beier
Journal:  Parasitol Int       Date:  2011-07-13       Impact factor: 2.230

7.  Differential roles of an Anopheline midgut GPI-anchored protein in mediating Plasmodium falciparum and Plasmodium vivax ookinete invasion.

Authors:  Derrick K Mathias; Juliette G Jardim; Lindsay A Parish; Jennifer S Armistead; Hung V Trinh; Chalermpon Kumpitak; Jetsumon Sattabongkot; Rhoel R Dinglasan
Journal:  Infect Genet Evol       Date:  2014-06-11       Impact factor: 3.342

Review 8.  The effects of ingested mammalian blood factors on vector arthropod immunity and physiology.

Authors:  Nazzy Pakpour; Leyla Akman-Anderson; Yoram Vodovotz; Shirley Luckhart
Journal:  Microbes Infect       Date:  2013-01-28       Impact factor: 2.700

9.  No evidence for positive selection at two potential targets for malaria transmission-blocking vaccines in Anopheles gambiae s.s.

Authors:  Jacob E Crawford; Susan M Rottschaefer; Boubacar Coulibaly; Madjou Sacko; Oumou Niaré; Michelle M Riehle; Sékou F Traore; Kenneth D Vernick; Brian P Lazzaro
Journal:  Infect Genet Evol       Date:  2013-01-26       Impact factor: 3.342

10.  Plasmodium-Mosquito Interactions: A Tale of Roadblocks and Detours.

Authors:  Ryan C Smith; Marcelo Jacobs-Lorena
Journal:  Adv In Insect Phys       Date:  2010       Impact factor: 3.364
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.